ムスカリン性アセチルコリン受容体の世界市場 2020年：メーカー別、地域別、種類・用途別

• 英文タイトル：Global Muscarinic Acetylcholine Receptor Market 2020 by Manufacturers, Regions, Type and Application, Forecast to 2025

• レポートコード：D005-10931 • 出版社/出版日：GlobalInfoResearch / 2020年5月28日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール • 産業分類：医療・製薬

• 販売価格（消費税別）

Single User	￥522,000 (USD3,480)	▷ お問い合わせ
Multi User	￥783,000 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,044,000 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

本調査レポートでは、ムスカリン性アセチルコリン受容体の世界市場を広く調査・分析し、今後の市場展望をまとめております。ムスカリン性アセチルコリン受容体の種類別市場規模（M1、M4、M5、その他）、用途別市場規模（注意欠陥多動性障害、精神障害、アルツハイマー病、慢性閉塞性肺疾患、記憶障害）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Anavex Life Sciences Corp、Karuna Pharmaceuticals Inc、AstraZeneca Plc、Heptares Therapeutics Ltd、Sumitomo Dainippon Pharma Co Ltd、NeuroHealing Pharmaceuticals Inc ・地域別グローバル市場分析 2015年-2020年 ・ムスカリン性アセチルコリン受容体の北米市場（アメリカ、カナダ、メキシコ） ・ムスカリン性アセチルコリン受容体のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・ムスカリン性アセチルコリン受容体のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・ムスカリン性アセチルコリン受容体の南米市場（ブラジル、アルゼンチン） ・ムスカリン性アセチルコリン受容体の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：M1、M4、M5、その他 ・用途別分析：注意欠陥多動性障害、精神障害、アルツハイマー病、慢性閉塞性肺疾患、記憶障害 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論

Market Overview
The global Muscarinic Acetylcholine Receptor market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.

The Muscarinic Acetylcholine Receptor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

Market segmentation
Muscarinic Acetylcholine Receptor market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

By Type, Muscarinic Acetylcholine Receptor market has been segmented into
M1
M4
M5
Others

By Application, Muscarinic Acetylcholine Receptor has been segmented into:
Attention Deficit Hyperactivity Disorder
Psychiatric Disorders
Alzheimer’s Disease
Chronic Obstructive Pulmonary Disease
Memory Impairment

Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Muscarinic Acetylcholine Receptor market presented in the report. This section sheds light on the sales growth of different regional and country-level Muscarinic Acetylcholine Receptor markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Muscarinic Acetylcholine Receptor market.

The report offers in-depth assessment of the growth and other aspects of the Muscarinic Acetylcholine Receptor market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)

Competitive Landscape and Muscarinic Acetylcholine Receptor Market Share Analysis
Muscarinic Acetylcholine Receptor competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Muscarinic Acetylcholine Receptor sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Muscarinic Acetylcholine Receptor sales, revenue and market share for each player covered in this report.

The major players covered in Muscarinic Acetylcholine Receptor are:
Anavex Life Sciences Corp
Karuna Pharmaceuticals Inc
AstraZeneca Plc
Heptares Therapeutics Ltd
Sumitomo Dainippon Pharma Co Ltd
NeuroHealing Pharmaceuticals Inc

Among other players domestic and global, Muscarinic Acetylcholine Receptor market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.

The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Muscarinic Acetylcholine Receptor product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Muscarinic Acetylcholine Receptor, with price, sales, revenue and global market share of Muscarinic Acetylcholine Receptor in 2018 and 2019.
Chapter 3, the Muscarinic Acetylcholine Receptor competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Muscarinic Acetylcholine Receptor breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Muscarinic Acetylcholine Receptor market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Muscarinic Acetylcholine Receptor sales channel, distributors, customers, research findings and conclusion, appendix and data source.

レポート目次

---

Table of Contents

1 Market Overview
1.1 Muscarinic Acetylcholine Receptor Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Muscarinic Acetylcholine Receptor Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 M1
1.2.3 M4
1.2.4 M5
1.2.5 Others
1.3 Market Analysis by Application
1.3.1 Overview: Global Muscarinic Acetylcholine Receptor Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Attention Deficit Hyperactivity Disorder
1.3.3 Psychiatric Disorders
1.3.4 Alzheimer’s Disease
1.3.5 Chronic Obstructive Pulmonary Disease
1.3.6 Memory Impairment
1.4 Overview of Global Muscarinic Acetylcholine Receptor Market
1.4.1 Global Muscarinic Acetylcholine Receptor Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Anavex Life Sciences Corp
2.1.1 Anavex Life Sciences Corp Details
2.1.2 Anavex Life Sciences Corp Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Anavex Life Sciences Corp SWOT Analysis
2.1.4 Anavex Life Sciences Corp Product and Services
2.1.5 Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Karuna Pharmaceuticals Inc
2.2.1 Karuna Pharmaceuticals Inc Details
2.2.2 Karuna Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Karuna Pharmaceuticals Inc SWOT Analysis
2.2.4 Karuna Pharmaceuticals Inc Product and Services
2.2.5 Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 AstraZeneca Plc
2.3.1 AstraZeneca Plc Details
2.3.2 AstraZeneca Plc Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 AstraZeneca Plc SWOT Analysis
2.3.4 AstraZeneca Plc Product and Services
2.3.5 AstraZeneca Plc Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Heptares Therapeutics Ltd
2.4.1 Heptares Therapeutics Ltd Details
2.4.2 Heptares Therapeutics Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Heptares Therapeutics Ltd SWOT Analysis
2.4.4 Heptares Therapeutics Ltd Product and Services
2.4.5 Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Sumitomo Dainippon Pharma Co Ltd
2.5.1 Sumitomo Dainippon Pharma Co Ltd Details
2.5.2 Sumitomo Dainippon Pharma Co Ltd Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Sumitomo Dainippon Pharma Co Ltd SWOT Analysis
2.5.4 Sumitomo Dainippon Pharma Co Ltd Product and Services
2.5.5 Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 NeuroHealing Pharmaceuticals Inc
2.6.1 NeuroHealing Pharmaceuticals Inc Details
2.6.2 NeuroHealing Pharmaceuticals Inc Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 NeuroHealing Pharmaceuticals Inc SWOT Analysis
2.6.4 NeuroHealing Pharmaceuticals Inc Product and Services
2.6.5 NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Muscarinic Acetylcholine Receptor Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Muscarinic Acetylcholine Receptor Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Muscarinic Acetylcholine Receptor Manufacturer Market Share in 2019
3.3.2 Top 6 Muscarinic Acetylcholine Receptor Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Muscarinic Acetylcholine Receptor Sales, Revenue and Market Share by Regions
4.1.1 Global Muscarinic Acetylcholine Receptor Sales and Market Share by Regions (2015-2020)
4.1.2 Global Muscarinic Acetylcholine Receptor Revenue and Market Share by Regions (2015-2020)
4.2 North America Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
4.3 Europe Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
4.5 South America Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Muscarinic Acetylcholine Receptor Sales, Revenue and Market Share by Country
5.1.1 North America Muscarinic Acetylcholine Receptor Sales and Market Share by Country (2015-2020)
5.1.2 North America Muscarinic Acetylcholine Receptor Revenue and Market Share by Country (2015-2020)
5.2 United States Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
5.3 Canada Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
5.4 Mexico Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Muscarinic Acetylcholine Receptor Sales, Revenue and Market Share by Country
6.1.1 Europe Muscarinic Acetylcholine Receptor Sales and Market Share by Country (2015-2020)
6.1.2 Europe Muscarinic Acetylcholine Receptor Revenue and Market Share by Country (2015-2020)
6.2 Germany Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
6.3 UK Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
6.4 France Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
6.5 Russia Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
6.6 Italy Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Muscarinic Acetylcholine Receptor Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Muscarinic Acetylcholine Receptor Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Muscarinic Acetylcholine Receptor Revenue and Market Share by Regions (2015-2020)
7.2 China Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
7.3 Japan Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
7.4 Korea Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
7.5 India Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
7.7 Australia Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Muscarinic Acetylcholine Receptor Sales, Revenue and Market Share by Country
8.1.1 South America Muscarinic Acetylcholine Receptor Sales and Market Share by Country (2015-2020)
8.1.2 South America Muscarinic Acetylcholine Receptor Revenue and Market Share by Country (2015-2020)
8.2 Brazil Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
8.3 Argentina Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Muscarinic Acetylcholine Receptor Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Muscarinic Acetylcholine Receptor Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Muscarinic Acetylcholine Receptor Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
9.3 Turkey Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
9.4 Egypt Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
9.5 South Africa Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Muscarinic Acetylcholine Receptor Sales and Market Share by Type (2015-2020)
10.2 Global Muscarinic Acetylcholine Receptor Revenue and Market Share by Type (2015-2020)
10.3 Global Muscarinic Acetylcholine Receptor Price by Type (2015-2020)
11 Global Muscarinic Acetylcholine Receptor Market Segment by Application
11.1 Global Muscarinic Acetylcholine Receptor Sales Market Share by Application (2015-2020)
11.2 Global Muscarinic Acetylcholine Receptor Revenue Market Share by Application (2015-2020)
11.3 Global Muscarinic Acetylcholine Receptor Price by Application (2015-2020)
12 Market Forecast
12.1 Global Muscarinic Acetylcholine Receptor Sales, Revenue and Growth Rate (2021-2025)
12.2 Muscarinic Acetylcholine Receptor Market Forecast by Regions (2021-2025)
12.2.1 North America Muscarinic Acetylcholine Receptor Market Forecast (2021-2025)
12.2.2 Europe Muscarinic Acetylcholine Receptor Market Forecast (2021-2025)
12.2.3 Asia-Pacific Muscarinic Acetylcholine Receptor Market Forecast (2021-2025)
12.2.4 South America Muscarinic Acetylcholine Receptor Market Forecast (2021-2025)
12.2.5 Middle East & Africa Muscarinic Acetylcholine Receptor Market Forecast (2021-2025)
12.3 Muscarinic Acetylcholine Receptor Market Forecast by Type (2021-2025)
12.3.1 Global Muscarinic Acetylcholine Receptor Sales Forecast by Type (2021-2025)
12.3.2 Global Muscarinic Acetylcholine Receptor Market Share Forecast by Type (2021-2025)
12.4 Muscarinic Acetylcholine Receptor Market Forecast by Application (2021-2025)
12.4.1 Global Muscarinic Acetylcholine Receptor Sales Forecast by Application (2021-2025)
12.4.2 Global Muscarinic Acetylcholine Receptor Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US

List of Tables

Table 1. Global Muscarinic Acetylcholine Receptor Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Muscarinic Acetylcholine Receptor by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Muscarinic Acetylcholine Receptor Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Anavex Life Sciences Corp Basic Information, Manufacturing Base and Competitors
Table 8. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Major Business
Table 9. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Total Revenue (USD Million) (2018-2019)
Table 10. Anavex Life Sciences Corp SWOT Analysis
Table 11. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Product and Services
Table 12. Anavex Life Sciences Corp Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Karuna Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 14. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Major Business
Table 15. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Total Revenue (USD Million) (2018-2019)
Table 16. Karuna Pharmaceuticals Inc SWOT Analysis
Table 17. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product and Services
Table 18. Karuna Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. AstraZeneca Plc Basic Information, Manufacturing Base and Competitors
Table 20. AstraZeneca Plc Muscarinic Acetylcholine Receptor Major Business
Table 21. AstraZeneca Plc Muscarinic Acetylcholine Receptor Total Revenue (USD Million) (2018-2019)
Table 22. AstraZeneca Plc SWOT Analysis
Table 23. AstraZeneca Plc Muscarinic Acetylcholine Receptor Product and Services
Table 24. AstraZeneca Plc Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Heptares Therapeutics Ltd Basic Information, Manufacturing Base and Competitors
Table 26. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Major Business
Table 27. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Total Revenue (USD Million) (2018-2019)
Table 28. Heptares Therapeutics Ltd SWOT Analysis
Table 29. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Product and Services
Table 30. Heptares Therapeutics Ltd Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Sumitomo Dainippon Pharma Co Ltd Basic Information, Manufacturing Base and Competitors
Table 32. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Major Business
Table 33. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Total Revenue (USD Million) (2018-2019)
Table 34. Sumitomo Dainippon Pharma Co Ltd SWOT Analysis
Table 35. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Product and Services
Table 36. Sumitomo Dainippon Pharma Co Ltd Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. NeuroHealing Pharmaceuticals Inc Basic Information, Manufacturing Base and Competitors
Table 38. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Major Business
Table 39. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Total Revenue (USD Million) (2018-2019)
Table 40. NeuroHealing Pharmaceuticals Inc SWOT Analysis
Table 41. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Product and Services
Table 42. NeuroHealing Pharmaceuticals Inc Muscarinic Acetylcholine Receptor Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Muscarinic Acetylcholine Receptor Sales by Manufacturer (2018-2019) (K MT)
Table 44. Global Muscarinic Acetylcholine Receptor Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Muscarinic Acetylcholine Receptor Sales by Regions (2015-2020) (K MT)
Table 46. Global Muscarinic Acetylcholine Receptor Sales Market Share by Regions (2015-2020)
Table 47. Global Muscarinic Acetylcholine Receptor Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Muscarinic Acetylcholine Receptor Sales by Countries (2015-2020) (K MT)
Table 49. North America Muscarinic Acetylcholine Receptor Sales Market Share by Countries (2015-2020)
Table 50. North America Muscarinic Acetylcholine Receptor Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Muscarinic Acetylcholine Receptor Revenue Market Share by Countries (2015-2020)
Table 52. Europe Muscarinic Acetylcholine Receptor Sales by Countries (2015-2020) (K MT)
Table 53. Europe Muscarinic Acetylcholine Receptor Sales Market Share by Countries (2015-2020)
Table 54. Europe Muscarinic Acetylcholine Receptor Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Muscarinic Acetylcholine Receptor Sales by Regions (2015-2020) (K MT)
Table 56. Asia-Pacific Muscarinic Acetylcholine Receptor Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Muscarinic Acetylcholine Receptor Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Muscarinic Acetylcholine Receptor Sales by Countries (2015-2020) (K MT)
Table 59. South America Muscarinic Acetylcholine Receptor Sales Market Share by Countries (2015-2020)
Table 60. South America Muscarinic Acetylcholine Receptor Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Muscarinic Acetylcholine Receptor Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Muscarinic Acetylcholine Receptor Sales by Countries (2015-2020) (K MT)
Table 63. Middle East & Africa Muscarinic Acetylcholine Receptor Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Muscarinic Acetylcholine Receptor Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Muscarinic Acetylcholine Receptor Revenue Market Share by Countries (2015-2020)
Table 66. Global Muscarinic Acetylcholine Receptor Sales by Type (2015-2020) (K MT)
Table 67. Global Muscarinic Acetylcholine Receptor Sales Share by Type (2015-2020)
Table 68. Global Muscarinic Acetylcholine Receptor Revenue by Type (2015-2020) (USD Million)
Table 69. Global Muscarinic Acetylcholine Receptor Revenue Share by Type (2015-2020)
Table 70. Global Muscarinic Acetylcholine Receptor Sales by Application (2015-2020) (K MT)
Table 71. Global Muscarinic Acetylcholine Receptor Sales Share by Application (2015-2020)
Table 72. Global Muscarinic Acetylcholine Receptor Sales Forecast by Regions (2021-2025) (K MT)
Table 73. Global Muscarinic Acetylcholine Receptor Market Share Forecast by Regions (2021-2025)
Table 74. Global Muscarinic Acetylcholine Receptor Sales Forecast by Type (2021-2025) (K MT)
Table 75. Global Muscarinic Acetylcholine Receptor Market Share Forecast by Type (2021-2025)
Table 76. Global Muscarinic Acetylcholine Receptor Sales Forecast by Application (2021-2025)
Table 77. Global Muscarinic Acetylcholine Receptor Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Muscarinic Acetylcholine Receptor Picture
Figure 2. Global Sales Market Share of Muscarinic Acetylcholine Receptor by Type in 2019
Figure 3. M1 Picture
Figure 4. M4 Picture
Figure 5. M5 Picture
Figure 6. Others Picture
Figure 7. Muscarinic Acetylcholine Receptor Sales Market Share by Application in 2018
Figure 8. Attention Deficit Hyperactivity Disorder Picture
Figure 9. Psychiatric Disorders Picture
Figure 10. Alzheimer's Disease Picture
Figure 11. Chronic Obstructive Pulmonary Disease Picture
Figure 12. Memory Impairment Picture
Figure 13. Global Muscarinic Acetylcholine Receptor Market Status and Outlook (2015-2025) (USD Million)
Figure 14. United States Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Canada Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Mexico Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Germany Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 18. France Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 19. UK Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Russia Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Italy Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 22. China Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Japan Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Korea Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 25. India Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Southeast Asia Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Australia Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 28. Brazil Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Egypt Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Saudi Arabia Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 31. South Africa Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Turkey Muscarinic Acetylcholine Receptor Revenue (Value) and Growth Rate (2015-2025)
Figure 33. Global Muscarinic Acetylcholine Receptor Sales Market Share by Manufacturer in 2019
Figure 34. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Manufacturer in 2019
Figure 35. Top 3 Muscarinic Acetylcholine Receptor Manufacturer (Revenue) Market Share in 2019
Figure 36. Top 6 Muscarinic Acetylcholine Receptor Manufacturer (Revenue) Market Share in 2019
Figure 37. Key Manufacturer Market Share Trend
Figure 38. Global Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 39. Global Muscarinic Acetylcholine Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 40. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Regions (2015-2020)
Figure 41. Global Muscarinic Acetylcholine Receptor Revenue Market Share by Regions in 2018
Figure 42. North America Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
Figure 43. Europe Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
Figure 44. Asia-Pacific Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
Figure 45. South America Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
Figure 46. Middle East & Africa Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020)
Figure 47. North America Muscarinic Acetylcholine Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 48. North America Muscarinic Acetylcholine Receptor Sales Market Share by Countries (2015-2020)
Figure 49. North America Muscarinic Acetylcholine Receptor Sales Market Share by Countries in 2018
Figure 50. North America Muscarinic Acetylcholine Receptor Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 51. North America Muscarinic Acetylcholine Receptor Revenue Market Share by Countries in 2018
Figure 52. United States Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 53. Canada Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 54. Mexico Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 55. Europe Muscarinic Acetylcholine Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 56. Europe Muscarinic Acetylcholine Receptor Revenue Market Share by Countries (2015-2020)
Figure 57. Europe Muscarinic Acetylcholine Receptor Revenue Market Share by Countries in 2019
Figure 58. Germany Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 59. UK Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 60. France Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 61. Russia Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 62. Italy Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 63. Asia-Pacific Muscarinic Acetylcholine Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 64. Asia-Pacific Muscarinic Acetylcholine Receptor Sales Market Share by Regions 2019
Figure 65. Asia-Pacific Muscarinic Acetylcholine Receptor Revenue Market Share by Regions 2019
Figure 66. China Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 67. Japan Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 68. Korea Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 69. India Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 70. Southeast Asia Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 71. South America Muscarinic Acetylcholine Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 72. South America Muscarinic Acetylcholine Receptor Sales Market Share by Countries in 2019
Figure 73. South America Muscarinic Acetylcholine Receptor Revenue Market Share by Countries in 2019
Figure 74. Brazil Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 75. Argentina Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 76. Middle East and Africa Muscarinic Acetylcholine Receptor Revenue and Growth Rate (2015-2020) (USD Million)
Figure 77. Middle East and Africa Muscarinic Acetylcholine Receptor Sales Market Share by Countries in 2019
Figure 78. Middle East and Africa Muscarinic Acetylcholine Receptor Revenue Market Share by Countries (2015-2020)
Figure 79. Middle East and Africa Muscarinic Acetylcholine Receptor Revenue Market Share by Countries in 2019
Figure 80. Saudi Arabia Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 81. Egypt Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 82. Turkey Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 83. South Africa Muscarinic Acetylcholine Receptor Sales and Growth Rate (2015-2020) (K MT)
Figure 84. Global Muscarinic Acetylcholine Receptor Sales and Growth Rate (2021-2025) (K MT)
Figure 85. Global Muscarinic Acetylcholine Receptor Revenue and Growth Rate (2021-2025) (USD Million)
Figure 86. North America Sales Muscarinic Acetylcholine Receptor Market Forecast (2021-2025) (K MT)
Figure 87. Europe Sales Muscarinic Acetylcholine Receptor Market Forecast (2021-2025) (K MT)
Figure 88. Asia-Pacific Sales Muscarinic Acetylcholine Receptor Market Forecast (2021-2025) (K MT)
Figure 89. South America Sales Muscarinic Acetylcholine Receptor Market Forecast (2021-2025) (K MT)
Figure 90. Middle East & Africa Sales Muscarinic Acetylcholine Receptor Market Forecast (2021-2025) (K MT)
Figure 91. Sales Channel: Direct Channel vs Indirect Channel

---